Table 1.

Calculated risk ratio and Manders’ coefficients for each association of TLR9 with VAMPs 5, 7, and 8

 Resting Spread (glass) 
Colocalization with TLR9 Rr M1 TLR9/VAMP M2 VAMP/TLR9 Rr M1 TLR9/VAMP M2 VAMP/TLR9 
VAMP 5 0.7 ± 0.1 0.4 ± 0.2 0.4 ± 0.2 0.5 ± 0.1 0.5 ± 0.2 0.14 ± 0.04 
VAMP 7 0.84 ± 0.02 0.82 ± 0.08 0.4 ± 0.1 0.69 ± 0.09 0.56 ± 0.08 0.32 ± 0.09 
VAMP 8 0.50 ± 0.03 0.77 ± 0.02 0.59 ± 0.02 0.4 ± 0.1 0.68 ± 0.04 0.4 ± 0.2 
 Resting Spread (glass) 
Colocalization with TLR9 Rr M1 TLR9/VAMP M2 VAMP/TLR9 Rr M1 TLR9/VAMP M2 VAMP/TLR9 
VAMP 5 0.7 ± 0.1 0.4 ± 0.2 0.4 ± 0.2 0.5 ± 0.1 0.5 ± 0.2 0.14 ± 0.04 
VAMP 7 0.84 ± 0.02 0.82 ± 0.08 0.4 ± 0.1 0.69 ± 0.09 0.56 ± 0.08 0.32 ± 0.09 
VAMP 8 0.50 ± 0.03 0.77 ± 0.02 0.59 ± 0.02 0.4 ± 0.1 0.68 ± 0.04 0.4 ± 0.2 

Calculated risk ratio (Rr) and Manders’ coefficients for each association of TLR9 with VAMPs 5, 7, and 8 in human whole-blood PLTs under resting conditions and when activated (spread) on glass surface. Manders’ coefficients of 0.5 or greater were considered significant and are highlighted in bold.

or Create an Account

Close Modal
Close Modal